GM

Glenn Mario Saldanha

Active Director Managing Director DIN 00050607
DIN 00050607 First appointment Oct 1998 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Oct 1998
Shareholding value •••• Premium profile

About Glenn Mario Saldanha

Data last updated:

Glenn Mario Saldanha has 28 years in corporate governance. Holds Managing Director and Director roles. Currently with 3 companies, including Glenmark Pharmaceuticals Limited and Glenmark Generics Limited. Formerly with 5 companies, such as Alivus Life Sciences Limited and Talwalkars Better Value Fitness Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Glenmark Pharmaceuticals Limited at ₹17,443 Cr (FY 2026).

DIN 00050607
Primary Designation Managing Director
First Appointment 12 Oct 1998
Oldest Company Age 48 yrs
Largest company Glenmark Pharmaceuticals Limited · ₹17,443 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glenmark Pharmaceuticals Limited L24299MH1977PLC019982
Managing Director12 Oct 19981977₹17,443 Cr (FY 2026)Active
Glenmark Consumer Care Limited U21001MH2025PLC449082
Director23 May 20252025–Active
Glenmark Healthcare Limited U21001MH2023PLC402796
Director12 May 20232023–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alivus Life Sciences Limited L74900PN2011PLC139963
Director06 Jul 20182011₹2,421 Cr (FY 2025)Active
Director09 Oct 20092003₹58.08 Cr (FY 2018)Under Liquidation
Glenmark Generics Limited U24110MH1994PLC081597
Director18 Dec 20071994–Amalgamated
Gm Pharma Limited U24230MH1999PLC121475
Director26 Sep 20021999–Amalgamated
Glenmark Access Limited U51900MH1996PLC102125
Director28 Sep 20011996–Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Glenmark Pharmaceuticals Limited
Glenmark Generics Limited
Gm Pharma Limited
Glenmark Access Limited
Premium access

Shareholding and investment profile for Glenn Mario Saldanha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Glenn Mario Saldanha

Glenn Mario Saldanha has 28 years in corporate governance. Holds Managing Director and Director roles. Currently with 3 companies, including Glenmark Pharmaceuticals Limited and Glenmark Generics Limited. Formerly with 5 companies, such as Alivus Life Sciences Limited and Talwalkars Better Value Fitness Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Glenmark Pharmaceuticals Limited at ₹17,443 Cr (FY 2026).

Glenn Mario Saldanha is associated with 3 companies as Managing Director and Director, including Glenmark Pharmaceuticals Limited (₹17,443 Cr), Glenmark Consumer Care Limited, Glenmark Healthcare Limited.

Glenn Mario Saldanha has expertise in General Business, Healthcare.

Glenn Mario Saldanha has 28 years in corporate governance.

By reported revenue, the largest current company of Glenn Mario Saldanha is Glenmark Pharmaceuticals Limited, with revenue of ₹17,443 Cr (FY 2026).

Glenn Mario Saldanha currently holds positions at 3 companies: Glenmark Pharmaceuticals Limited (₹17,443 Cr), Glenmark Consumer Care Limited, Glenmark Healthcare Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available